Targeting interleukin-6 in immune-mediated inflammatory diseases: Current strategies and emerging technologies.
ABSTRACT Immune-mediated inflammatory diseases (IMIDs) refer to a heterogeneous group of conditions driven by dysregulated immune responses that affect multiple organs and systems, leading to substantial morbidity and premature mortality. Accumulating evidence indicates that excessive interleukin-6 (IL-6) production an...